Skip to content

PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

Medicine & Health

Rare cancers

Curated Collections

Rare cancers affect fewer than 6 per 100,000 people each year, yet as a group they are responsible for around a quarter of all cancer diagnoses. Rare cancers can also be associated with worse health outcomes and survival rates compared with more common cancers.

These inequities result from several challenges to the management of rare cancers including late diagnosis, limited availability of treatments, and difficulties recruiting sufficient patients for clinical studies.

There is increasing recognition of the need to address the burden of rare cancers, and ensure that they are not neglected from policy and research initiatives. This Collection highlights a selection of research on the biology and epidemiology of rare cancers, including several promising approaches for diagnosis and treatment.

This Collection has been curated by Guest Editor Mitesh J. Borad, M.D. Professor of Medicine at the Mayo Clinic Arizona.

Image Credit: Cancer cells by Dr. Cecil Fox National Cancer Institute

PLOS ONE, Medicine, and Genetics
READY TO SUBMIT?

Submit your research to PLOS ONE.

Submit now!
READY TO SUBMIT?

Submit your research to PLOS Genetics.

Submit now!
READY TO SUBMIT?

Submit your research to PLOS Medicine.

Submit now!
FOLLOW PLOS ON X (FORMERLY KNOWN AS TWITTER)

To keep up to date on the latest research.

Follow us
Back to top